| Title | Year Published | Product Code |
| AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update | 2011 | NA |
| Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease: Mechanistic, Research, and Clinical Considerations for Youth | 2011 | NA |
| Guidelines for the Primary Prevention of Stroke | 2010 | KB-0080 |
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary | 2010 | KB-0113 |
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Full Text | 2010 | KB-0112 |
| Impact of Smokeless Tobacco Products on Cardiovascular Disease | 2010 | KB-0079 |
| Call to Action: Cardiovascular Disease in Asian Americans | 2010 | KB-0078 |
| Translating Evidence Into Practice: A Decade of Efforts by the American Heart Association/American Stroke Association to Reduce Death and Disability Due to Stroke | 2010 | KB-0035 |
| Thiazolidinedione Drugs and Cardiovascular Risks | 2010 | KB-0036 |
AHA/ACS/AUA Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk | 2010 | KB-0015 |
| Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association’s Strategic Impact Goal Through 2020 and Beyond | 2010 | KB-0016 |
| Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity | 2009 | KJ-0730 |
| Worksite Wellness Programs for Cardiovascular Disease Prevention | 2009 | KJ-0733 |
| Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents: Recommendations for Standard Assessment for Clinical Research | 2009 | KJ-0729 |
| Exercise Training for Type 2 Diabetes Mellitus: Impact on Cardiovascular Risk | 2009 | LS-2091 |
| Criteria for Evaluation of Novel Markers of Cardiovascular Risk | 2009 | LS-2042 |
| Partnering to Reduce Risks and Improve Cardiovascular Outcomes | 2009 | LS-1939 |
| The American Heart Association's 2008 Statement of Principles for Healthcare Reform | 2008 | --- |
| Depression and Coronary Heart Disease: Recommendations for Screening, Referral, and Treatment | 2008 | 71-0456 |
| Medical Director Responsibilities for Outpatient Cardiac Rehabilitation/Secondary Prevention Programs | 2005 | 71-0337 |
Managing Abnormal Blood Lipids: A Collaborative Approach | 2005 | 71-0332 |
| Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement: Executive Summary | 2005 | 71-0336 |
| Exercise Testing in Asymptomatic Adults. A Statement for Professionals From the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention | 2005 | NA |
| Overweight in Children and Adolescents | 2005 | 71-0320 |
| CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease--Application to Clinical and Public Health Practice: Overview | 2004 | 71-0306 |
| CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease--Application to Clinical and Public Health Practice: Report From the Laboratory Science Discussion Group | 2004 | 71-0306 |
| CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease--Application to Clinical and Public Health Practice: Report From the Clinical Practice Discussion Group | 2004 | 71-0306 |
| CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease--Application to Clinical and Public Health Practice: Report From the Population Science Discussion Group | 2004 | 71-0306 |
| AHA Scientific Statement: Air Pollution and Cardiovascular Disease | 2004 | 71-0289 |
| Kidney Disease as a Risk Factor for Development of Cardiovascular Disease | 2003 | 71-0258 |
| AHA/CDC Scientific Statement: Markers of Inflammation and Cardiovascular Disease—Application to Clinical and Public Health Practice | 2003 | 71-0246 |
| Cardiovascular Health in Childhood | 2002 | 71-0229 |
| ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins | 2002 | 71-0234 |
| Secondary Prevention of Coronary Heart Disease in the Elderly (With Emphasis on Patients ≥75 Years of Age) | 2002 | 71-0224 |
| Exercise Standards for Testing and Training | 2001 | 71-0210 |
| AHA Science Advisory Assessment of Functional Capacity in Clinical and Research Applications | 2000 | 71-0190 |
| AHA/AACVPR Scientific Statement Core Components of Cardiac Rehabilitation/Secondary Prevention Programs | 2000 | 71-0186 |
Prevention Conference V: Beyond Secondary Prevention: Identifying the High-Risk Patient for Primary Prevention: Executive Summary | 2000 | 71-0181 |
| Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations | 1999 | 71-0177 |
| Diabetes and Cardiovascular Disease | 1999 | 71-0175 |
| Primary Prevention of Coronary Heart Disease: Guidance From Framingham | 1998 | 71-0139 |
| Optimal Risk Factor Management in the Patient After Coronary Revascularization | 1994 | 71-0062 |
Ten Years of Images from Circulation
